Cargando…

Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats

Dysbiosis of the gut microbiota is associated with the pathogenesis of intestinal diseases such as inflammatory bowel disease, irritable bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO), and metabolic disease states such as allergies, cardiovascular diseases, obesity, and diabetes....

Descripción completa

Detalles Bibliográficos
Autores principales: Aslan, Ismail, Tarhan Celebi, Leyla, Kayhan, Hulya, Kizilay, Emine, Gulbahar, Mustafa Yavuz, Kurt, Halil, Cakici, Bekir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383999/
https://www.ncbi.nlm.nih.gov/pubmed/37513952
http://dx.doi.org/10.3390/ph16071041
_version_ 1785081049561169920
author Aslan, Ismail
Tarhan Celebi, Leyla
Kayhan, Hulya
Kizilay, Emine
Gulbahar, Mustafa Yavuz
Kurt, Halil
Cakici, Bekir
author_facet Aslan, Ismail
Tarhan Celebi, Leyla
Kayhan, Hulya
Kizilay, Emine
Gulbahar, Mustafa Yavuz
Kurt, Halil
Cakici, Bekir
author_sort Aslan, Ismail
collection PubMed
description Dysbiosis of the gut microbiota is associated with the pathogenesis of intestinal diseases such as inflammatory bowel disease, irritable bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO), and metabolic disease states such as allergies, cardiovascular diseases, obesity, and diabetes. SIBO is a condition characterized by an increased number (>1 × 10(3) CFU) of abnormal bacterial species in the small intestine. Interest in SIBO has gained importance due to increased awareness of the human microbiome and its potential relationships with human health and disease, which has encouraged new work in this area. In recent years, standard antibiotic regimens (rifaximin and metronidazole) have been used to treat SIBO, but solo antibiotics or their derivatives are insufficient. In this study, the therapeutic effects of the probiotic form, which contains coconut oil and traces of peppermint-lemon-patchouli essential oil, were evaluated on the Dysbiosis-Based Rat SIBO Model. There are significant differences between sick and healthy rats (p = 0.014), between sick rats and rats treated with the oil mix plus probiotic mix protocol (p = 0.026), and between rats treated with only the probiotic and only oil protocols (p = 0.030) in the evaluation of TNF-α levels. Histologically, villi distortion and loss of crypts, epithelial shedding and necrotic changes in the apical regions of the villi, and inflammatory cell infiltrations extending to the lamina propria and submucosa were observed in sick rats. Mitotic figures in villus epithelium and crypts were observed in rats treated with 9.2 × 10(9) CFU/1000 mg/coconut oil + trace amounts of peppermint-lemon-patchouli essential oil and a probiotic mixture (oil + probiotic mix protocol). A regression of inflammatory reactions and an increase in goblet cells were observed. A decrease was observed in inflammation markers in sick rats. On the other hand, the oil plus probiotic mix protocol recovered digestive system defects in the animals caused by dysbiosis. In the future, these treatment approaches can be effective in the treatment of SIBO.
format Online
Article
Text
id pubmed-10383999
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103839992023-07-30 Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats Aslan, Ismail Tarhan Celebi, Leyla Kayhan, Hulya Kizilay, Emine Gulbahar, Mustafa Yavuz Kurt, Halil Cakici, Bekir Pharmaceuticals (Basel) Article Dysbiosis of the gut microbiota is associated with the pathogenesis of intestinal diseases such as inflammatory bowel disease, irritable bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO), and metabolic disease states such as allergies, cardiovascular diseases, obesity, and diabetes. SIBO is a condition characterized by an increased number (>1 × 10(3) CFU) of abnormal bacterial species in the small intestine. Interest in SIBO has gained importance due to increased awareness of the human microbiome and its potential relationships with human health and disease, which has encouraged new work in this area. In recent years, standard antibiotic regimens (rifaximin and metronidazole) have been used to treat SIBO, but solo antibiotics or their derivatives are insufficient. In this study, the therapeutic effects of the probiotic form, which contains coconut oil and traces of peppermint-lemon-patchouli essential oil, were evaluated on the Dysbiosis-Based Rat SIBO Model. There are significant differences between sick and healthy rats (p = 0.014), between sick rats and rats treated with the oil mix plus probiotic mix protocol (p = 0.026), and between rats treated with only the probiotic and only oil protocols (p = 0.030) in the evaluation of TNF-α levels. Histologically, villi distortion and loss of crypts, epithelial shedding and necrotic changes in the apical regions of the villi, and inflammatory cell infiltrations extending to the lamina propria and submucosa were observed in sick rats. Mitotic figures in villus epithelium and crypts were observed in rats treated with 9.2 × 10(9) CFU/1000 mg/coconut oil + trace amounts of peppermint-lemon-patchouli essential oil and a probiotic mixture (oil + probiotic mix protocol). A regression of inflammatory reactions and an increase in goblet cells were observed. A decrease was observed in inflammation markers in sick rats. On the other hand, the oil plus probiotic mix protocol recovered digestive system defects in the animals caused by dysbiosis. In the future, these treatment approaches can be effective in the treatment of SIBO. MDPI 2023-07-22 /pmc/articles/PMC10383999/ /pubmed/37513952 http://dx.doi.org/10.3390/ph16071041 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Aslan, Ismail
Tarhan Celebi, Leyla
Kayhan, Hulya
Kizilay, Emine
Gulbahar, Mustafa Yavuz
Kurt, Halil
Cakici, Bekir
Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats
title Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats
title_full Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats
title_fullStr Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats
title_full_unstemmed Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats
title_short Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats
title_sort probiotic formulations containing fixed and essential oils ameliorates sibo-induced gut dysbiosis in rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383999/
https://www.ncbi.nlm.nih.gov/pubmed/37513952
http://dx.doi.org/10.3390/ph16071041
work_keys_str_mv AT aslanismail probioticformulationscontainingfixedandessentialoilsamelioratessiboinducedgutdysbiosisinrats
AT tarhancelebileyla probioticformulationscontainingfixedandessentialoilsamelioratessiboinducedgutdysbiosisinrats
AT kayhanhulya probioticformulationscontainingfixedandessentialoilsamelioratessiboinducedgutdysbiosisinrats
AT kizilayemine probioticformulationscontainingfixedandessentialoilsamelioratessiboinducedgutdysbiosisinrats
AT gulbaharmustafayavuz probioticformulationscontainingfixedandessentialoilsamelioratessiboinducedgutdysbiosisinrats
AT kurthalil probioticformulationscontainingfixedandessentialoilsamelioratessiboinducedgutdysbiosisinrats
AT cakicibekir probioticformulationscontainingfixedandessentialoilsamelioratessiboinducedgutdysbiosisinrats